Published in Prog Clin Biol Res on January 01, 1991
Expression of DeltaNp73 is a molecular marker for adverse outcome in neuroblastoma patients. Cell Death Differ (2002) 2.14
Quality assessment of genetic markers used for therapy stratification. J Clin Oncol (2003) 1.92
Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study). Br J Cancer (2011) 1.09
Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project. Br J Cancer (2012) 1.09
Accumulation of m-iodobenzylguanidine by neuroblastoma cells results from independent uptake and storage mechanisms. Cancer Res (1991) 1.08
Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification. Cancer Res (1999) 1.03
Fibrocartilaginous mesenchymoma of bone. Pathol Res Pract (1991) 0.99
A combined evaluation of biochemical and morphological changes during human neuroblastoma cell differentiation. Cell Mol Neurobiol (1992) 0.98
Expression of MAGE-1, MAGE-3 and MART-1 genes in neuroblastoma. Int J Cancer (1996) 0.97
DNA-functionalized solid state nanopore for biosensing. Nanotechnology (2010) 0.94
The expression of metalloproteinase-2, -9, and -14 and of tissue inhibitors-1 and -2 is developmentally modulated during osteogenesis in vitro, the mature osteoblastic phenotype expressing metalloproteinase-14. J Bone Miner Res (2000) 0.91
Erythroid differentiation and modulation of c-myc expression induced by antineoplastic drugs in the human leukemic cell line K562. Cancer Res (1987) 0.90
Effects of gamma-interferon on the growth, morphology, and membrane and cytoskeletal proteins expression of Lan-1 cells. Exp Cell Res (1989) 0.89
Localized unresectable neuroblastoma: results of treatment based on clinical prognostic factors. Ann Oncol (2002) 0.88
Induction of monocyte-macrophage differentiation in a new diploid line of human hematopoietic cells (CM-S) by phorbol esters. Cancer Res (1982) 0.88
[Plasma fibronectin in chronic liver diseases]. Recenti Prog Med (1993) 0.88
Proliferation-associated Brn-3b transcription factor can activate cyclin D1 expression in neuroblastoma and breast cancer cells. Oncogene (2007) 0.88
gamma-Interferon increases metaiodobenzylguanidine incorporation and retention in human neuroblastoma cells. Cancer Res (1992) 0.87
Somatostatin receptor type 2 gene expression in neuroblastoma, measured by competitive RT-PCR, is related to patient survival and to somatostatin receptor imaging by indium -111-pentetreotide. Med Pediatr Oncol (2001) 0.87
A new human highly tumorigenic neuroblastoma cell line with undetectable expression of N-myc. Pediatr Res (1990) 0.86
Genomic aberrations in normal appearing mucosa fields distal from oral potentially malignant lesions. Cell Oncol (Dordr) (2011) 0.86
p27Kip1 accumulation is associated with retinoic-induced neuroblastoma differentiation: evidence of a decreased proteasome-dependent degradation. Oncogene (2000) 0.86
T cells from lymphoepithelial thymoma produce a biochemical variant of IL-2. Lymphokine Res (1985) 0.86
Different p73 splicing variants are expressed in distinct tumour areas of a multifocal neuroblastoma. Cell Death Differ (1999) 0.86
Quantitative determination of sst2 gene expression in neuroblastoma tumor predicts patient outcome. J Clin Endocrinol Metab (2000) 0.86
Morphologic and phenotypic changes of human neuroblastoma cells in culture induced by cytosine arabinoside. Exp Cell Res (1989) 0.86
Angiogenic and angiostatic microenvironment in tumors--role of gangliosides. Acta Oncol (1997) 0.85
Uncoordinate induction and differential regulation of HLA class-I and class-II expression by gamma-interferon in differentiating human neuroblastoma cells. Int J Cancer (1993) 0.85
Biological and clinical role of p73 in neuroblastoma. Cancer Lett (2003) 0.84
Role of methylation in the control of DeltaNp73 expression in neuroblastoma. Cell Death Differ (2002) 0.84
Pancreatic dysfunction and its association with fat malabsorption in HIV infected children. Gut (1998) 0.82
Structural and functional analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in neuroblastoma. Pediatr Res (1998) 0.82
Electrical characterization of DNA-functionalized solid state nanopores for bio-sensing. J Phys Condens Matter (2010) 0.82
Isolation and functional assessment of common, polymorphic variants of the B-MYB proto-oncogene associated with a reduced cancer risk. Oncogene (2007) 0.82
Evidence of loss of N-myc amplification during the establishment of a human neuroblastoma cell line. Int J Cancer (1990) 0.81
Subcellular details of early events of differentiation induced by retinoic acid in human neuroblastoma cells detected by atomic force microscope. Exp Cell Res (1995) 0.81
PHOX2A and PHOX2B genes are highly co-expressed in human neuroblastoma. Int J Oncol (2008) 0.81
Late Epstein-Barr virus infection of a hepatosplenic gamma delta T-cell lymphoma arising in a kidney transplant recipient. Haematologica (2000) 0.81
Stimulation of receptor-coupled phospholipase A2 by interferon-gamma. FEBS Lett (1992) 0.81
Cytogenetic and molecular study of two human neuroblastoma cell lines. Cancer Genet Cytogenet (1988) 0.81
[Diminished in vitro colony forming capacity of bone marrow cells in a case of chromosome 8 trisomy (mosaicism): criteria for "high risk" pre-leukemia syndrome]. Boll Ist Sieroter Milan (1981) 0.81
Detection of DNA polymorphisms and point mutations of high-affinity nerve growth factor receptor (TrkA) in human neuroblastoma. Int J Oncol (1999) 0.80
Interstitial and large chromosome 1p deletion occurs in localized and disseminated neuroblastomas and predicts an unfavourable outcome. Cancer Lett (1998) 0.80
Lack of p73 expression in mature B-ALL and identification of three new splicing variants restricted to pre B and C-ALL indicate a role of p73 in B cell ALL differentiation. Leukemia (2000) 0.80
The combination of gamma-interferon and tumor necrosis factor causes a rapid and extensive differentiation of human neuroblastoma cells. Cancer Res (1992) 0.80
Lymphoblastoid cells transfected with c-myc: downregulation of EBV-lytic antigens and impaired response of autologous CD4+ T cells in vitro. Int J Cancer (1996) 0.80
A novel approach in personal identification from tissue samples undergone different processes through STR typing. Forensic Sci Int (2004) 0.79
Impact of MDM2 SNP309 genotype on progression and survival of stage 4 neuroblastoma. Eur J Cancer (2008) 0.79
Expression of protein kinase C-alpha (PKC-alpha) and MYCN mRNAs in human neuroblastoma cells and modulation during morphological differentiation induced by retinoic acid. FEBS Lett (1991) 0.79
Protein kinase C isoenzymes in human neuroblasts. Involvement of PKC epsilon in cell differentiation. FEBS Lett (1993) 0.79
Real-time quantitative PCR for the measurement of MYCN amplification in human neuroblastoma with the TaqMan detection system. Clin Chem (1999) 0.79
Reduced expression of transforming growth factor-beta receptor type III in high stage neuroblastomas. Br J Cancer (2000) 0.79
Ankyrin deficiency is the most common defect in dominant and non dominant hereditary spherocytosis. Haematologica (1997) 0.79
Age-dependent prognostic significance of N-myc amplification in neuroblastoma. The Italian experience. Cancer Genet Cytogenet (1991) 0.79
Numerical and structural aberrations in advanced neuroblastoma tumours by CGH analysis; survival correlates with chromosome 17 status. Br J Cancer (2000) 0.79
N-myc amplification at chromosome band 1p32 in neuroblastoma cells as investigated by in situ hybridization. J Cancer Res Clin Oncol (1988) 0.79
Molecular alterations in a case of bilateral adrenal neuroblastoma. Med Pediatr Oncol (2001) 0.79
Immunological evaluation of 22 patients with acute lymphoblastic leukemia off-therapy. A longitudinal follow-up. Helv Paediatr Acta (1981) 0.78
Peculiar allelotype associated with susceptibility to neuroblastoma. Genes Chromosomes Cancer (1996) 0.78
Antiblastic treatment does not affect N-myc gene amplification in neuroblastoma. Anticancer Res (1987) 0.78
Coordinate change of c-myc, transferrin receptor and H3 gene expression precedes induction of haemoglobin-producing cells of the leukaemia K562 cell line treated with cis-diamminedichloroplatinum (II). Anticancer Res (1991) 0.78
N-myc oncogene amplification in a patient with IV-S neuroblastoma. Am J Pediatr Hematol Oncol (1987) 0.78
Detection of T cell receptor delta gene rearrangements in childhood B and T lineage acute lymphoblastic leukaemia by southern blot and PCR: technical comparison of two methods of analysis. Clin Lab Haematol (2000) 0.78
Neuroblastoma in two siblings supports the role of 1p36 deletion in tumor development. Cancer Genet Cytogenet (1999) 0.78
Inducible expression of calcyclin, a gene with strong homology to S-100 protein, during neuroblastoma cell differentiation and its prevalent expression in Schwann-like cell lines. Cancer Res (1991) 0.78
Retinoic acid inhibits phosphatidylinositol turnover only in RA-sensitive while not in RA-resistant human neuroblastoma cells. Biochem Biophys Res Commun (1989) 0.78
Expression of multiple drug resistance gene, MDR1, and N-myc oncogene in an Italian population of human neuroblastoma patients. Anticancer Res (1990) 0.78
Letter: Immunological side-effects of anticonvulsants. Lancet (1976) 0.78
Neurite outgrowth and cell cycle kinetic changes induced by cis-diamminedichloroplatinum II and retinoic acid in a human neuroblastoma cell line. Cancer Lett (1990) 0.78
N-myc gene amplification/expression in localized stroma-rich neuroblastoma (ganglioneuroblastoma). Hum Pathol (1993) 0.78
Serum HCV-RNA and liver histologic findings in patients with long-term normal transaminases. Dig Dis Sci (1997) 0.77
Experimental procedures comparing the activity of different Taq polymerases. Forensic Sci Int (2004) 0.77
Phosphorylase-mediated mobilization of the amino group of adenine in Bacillus cereus. Arch Biochem Biophys (1987) 0.77
Morphological change and cellular differentiation induced by cisplatin in human neuroblastoma cell lines. Cancer Chemother Pharmacol (1989) 0.77
Genome and transcriptome analysis of neuroblastoma advanced diagnosis from innovative therapies. Curr Pharm Des (2009) 0.77
Pleomorphic (anaplastic) neuroblastoma in nude mice. Arch Pathol Lab Med (1991) 0.77
Expression of histone H3 cell cycle-related gene, vimentin and MYC genes in pediatric brain tumors. A preliminary analysis showing the different malignant cell growth potential. Brain Res Mol Brain Res (1992) 0.77
Interferon-gamma-stimulated and GTP-binding-proteins-mediated phospholipase A2 activation in human neuroblasts. Biochem J (1993) 0.77
Stage-independent expression and genetic analysis of tp73 in neuroblastoma. Int J Cancer (1999) 0.77
Processing of human cord blood by three different procedures for red blood cell depletion and mononuclear cell recovery. Vox Sang (1999) 0.76
An oligomer complementary to the 5' end region of MDR1 gene decreases resistance to doxorubicin of human adenocarcinoma-resistant cells. Anticancer Res (1992) 0.76
Cloning and sequencing of isoform-specific regions of human Ca2+-independent protein kinase C (PKC)-encoding genes. Gene (1994) 0.76
N-myc oncogene amplification and catecholamine metabolism in patients with neuroblastoma. Lancet (1987) 0.76
Refined chromosomal localization of the putative tumor suppressor gene TP73. Cytogenet Cell Genet (1998) 0.76
Identification of an AP-1-like sequence in the promoter region of calcyclin, a S-100-like gene. Enhancement of binding during retinoic acid-induced neuroblastoma cell differentiation. Neurosci Lett (1994) 0.76
Modulation of alpha 1 beta 1, alpha 2 beta 1 and alpha 3 beta 1 integrin heterodimers during human neuroblastoma cell differentiation. FEBS Lett (1993) 0.76
Wilms' tumor after treatment. Pediatr Pathol (1992) 0.76
Pancreatic insufficiency in celiac disease is not dependent on nutritional status. Dig Dis Sci (1994) 0.76
Gamma-interferon, retinoic acid, and cytosine arabinoside induce neuroblastoma differentiation by different mechanisms. Cell Mol Neurobiol (1991) 0.76
N-myc oncogene amplification in a pediatric case of glioblastoma multiforme. Childs Nerv Syst (1991) 0.75
Prognostic significance of N-myc amplification in neuroblastoma. Clin Chem (1990) 0.75